What You Should Know About TDF
Patients diagnosed with human immunodeficiency virus (HIV) and prescribed medication to manage the...READ MORE
Gilead Sciences, Inc., a commercial pharmaceutical manufacturer, is facing thousands of lawsuits alleging negligence and fraud related to its TDF HIV medication. Many patients claim the HIV medication tenofovir disoproxil fumarate (TDF) has caused kidney disease and bone density loss.
Drugs with the brand names Truvada, Viread, Atripla, Stribild, and Complera contain TDF as a primary ingredient. These drugs are designed to help patients by keeping the HIV virus from multiplying and preventing HIV infection. However, the drugs have caused some individuals to suffer severe kidney damages and loss of bone mineral density.
Lawsuits against Gilead allege that it was developing other medications containing tenofovir alafenamide fumarate (TAF) around the time that it was developing its TDF medications. TAF has been shown to be more effective at stopping HIV from multiplying and safer for patients.
When companies put profits over the safety of consumers, they need to be held accountable. The attorneys at Baron & Budd are here to help and will work hard to hold them accountable for their conduct.
If you are thinking of taking action against Gilead, the attorneys at Baron & Budd can help you. Baron & Budd has a long track record of success in cases such as these. If you or someone you know took a medication containing TDF and developed kidney disease or bone density loss afterward, we may be able to help. Please call 866-723-1890 or contact us online to learn more.
* This article is not intended to provide any medical advice. Please consult with your physician prior to discontinuing use of any prescribed medication.